Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Letrozole in the Treatment of Severe and Recurrent Endometriosis

NCT00240942 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT00240942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Letrozole in the Treatment of Severe and Recurrent Endometriosis
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2002
Completion date
June 30, 2006
Enrollment
40
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe and recurrent endometriosis